<DOC>
	<DOC>NCT00518089</DOC>
	<brief_summary>The study will determine the safety and efficacy of gatifloxacin eye drops in patients with bacterial conjunctivitis</brief_summary>
	<brief_title>A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Bacterial</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Clinically diagnosed with bacterial conjunctivitis Signs and/or symptoms of conjunctivitis for more than 96 hours Signs and/or symptoms suggestive of fungal, viral, or allergic conjunctivitis Clinical diagnosis of chlamydia in either eye</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>